Trials / Completed
CompletedNCT04735406
The MS-LINK™ Outcomes Study
The MS-LINK™ Outcomes Study: A Comprehensive Prospective Longitudinal Assessment of Patient and Clinical Reported Outcomes in Multiple Sclerosis Patients Across North America
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,182 (actual)
- Sponsor
- EMD Serono Research & Development Institute, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Multiple Sclerosis (MS) Leadership and Innovation Network (MS-LINK™) is comprised of networks working cooperatively to advance Multiple Sclerosis (MS) science and improve MS participant outcomes. In this study participants will be followed from the time of consent through the lifetime of the study (currently 3 years), unless the participant chooses to withdraw from the study. Collection of participant's medical history, including MS and treatment history, will be automated through extraction from the participant's electronic medical record (EMR) and other health information systems (for example, radiology). Participants will complete patient-reported outcomes (PROs) and other health-related information digitally. Participating participants will have access to their own data in an ongoing manner via a web-based Participant Portal.
Conditions
Timeline
- Start date
- 2021-03-24
- Primary completion
- 2024-01-31
- Completion
- 2024-05-31
- First posted
- 2021-02-03
- Last updated
- 2024-08-22
Locations
9 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04735406. Inclusion in this directory is not an endorsement.